Fund Holdings — SUPERSTRING CAPITAL MANAGEMENT LP

Total Portfolio Value:
$80.27M
Total Bought:
$33.94M
Total Sold:
$39.66M
Net Transaction:
-$5.73M
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Cogent Biosciences, Inc.(COGT)774,721962,951+188,230$4.64M$6.91M8.61%+$2.27M
Verona Pharma PlcADS96,82168,982-27,839$6.15M$6.52M8.13%+$377.2K
Neurocrine Biosciences, Inc.(NBIX)040,608+40,608$0$5.10M6.36%+$5.10M
Terns Pharmaceuticals Inc1,357,1531,286,681-70,472$3.75M$4.80M5.98%+$1.05M
Ultragenyx Pharmaceutical Inc.(RARE)0130,422+130,422$0$4.74M5.91%+$4.74M
Zai Lab LimitedADR(ZLAB)294,947134,895-160,052$10.66M$4.72M5.88%-$5.94M
Jazz Pharmaceuticals plcSHS USD(JAZZ)044,107+44,107$0$4.68M5.83%+$4.68M
BridgeBio Pharma, Inc.(BBIO)183,92296,766-87,156$6.36M$4.18M5.21%-$2.18M
Travere Therapeutics, Inc.(TVTX)237,487276,474+38,987$4.26M$4.09M5.10%-$164.0K
Ionis Pharmaceuticals, Inc.(IONS)098,267+98,267$0$3.88M4.84%+$3.88M
ORIC Pharmaceuticals, Inc.(ORIC)819,194344,922-474,272$4.57M$3.50M4.36%-$1.07M
Soleno Therapeutics Inc19,33233,691+14,359$1.38M$2.82M3.52%+$1.44M
Savara Inc.(SVRA)966,2031,115,379+149,176$2.68M$2.54M3.17%-$133.3K
89bio Inc109,156212,377+103,221$793.6K$2.09M2.60%+$1.29M
Cytokinetics, Incorporated(CYTK)72,99261,103-11,889$2.93M$2.02M2.52%-$914.7K
Bicara Therapeutics Inc0189,699+189,699$0$1.76M2.20%+$1.76M
Cabaletta Bio, Inc.(CABA)458,9721,060,764+601,792$635.7K$1.61M2.01%+$976.7K
Tectonic Therapeutic, Inc.(TECX)50,74679,058+28,312$898.7K$1.57M1.96%+$672.2K
Insmed Incorporated(INSM)014,571+14,571$0$1.47M1.83%+$1.47M
United Therapeutics Corporation(UTHR)04,874+4,874$0$1.40M1.74%+$1.40M
Avidity Biosciences Inc22,27147,037+24,766$657.4K$1.34M1.66%+$678.4K
UroGen Pharma Ltd.(URGN)423,63287,912-335,720$4.69M$1.20M1.50%-$3.48M
Protara Therapeutics, Inc.(TARA)360,000360,0000$1.53M$1.09M1.36%-$442.8K
Zenas BioPharma, Inc.(ZBIO)111,605111,6050$881.7K$1.08M1.35%+$199.8K
Liquidia Corporation(LQDA)071,071+71,071$0$885.5K1.10%+$885.5K
MoonLake ImmunotherapeuticsCL A(MLTX)32,14517,623-14,522$1.26M$831.8K1.04%-$424.1K
Ocular Therapeutix, Inc.(OCUL)42,29788,980+46,683$310.0K$825.7K1.03%+$515.7K
Rocket Pharmaceuticals, Inc.(RCKT)0214,412+214,412$0$525.3K0.65%+$525.3K
Wave Life Sciences, Inc.SHS(WVE)070,242+70,242$0$456.6K0.57%+$456.6K
Biomea Fusion, Inc.(BMEA)0250,000+250,000$0$450.0K0.56%+$450.0K
Kyverna Therapeutics, Inc.(KYTX)191,287142,542-48,745$369.2K$437.6K0.55%+$68.4K
Century Therapeutics, Inc.(IPSC)462,963462,9630$220.4K$258.7K0.32%+$38.3K
So-Young International Inc.ADS(SY)072,936+72,936$0$226.1K0.28%+$226.1K
Rapt Therapeutics Inc026,034+26,034$0$208.3K0.26%+$208.3K
Lakeshore Biopharma Co Ltd30,79230,7920$74.5K$31.4K0.04%-$43.1K
Capricor Therapeutics, Inc.(CAPR)241,1920-241,192$2.29M$0—-$2.29M
Crinetics Pharmaceuticals In43,6130-43,613$1.46M$0—-$1.46M
Legend Biotech CorporationADS(LEGN)160,4420-160,442$5.44M$0—-$5.44M
Madrigal Pharmaceuticals, Inc.(MDGL)3,8150-3,815$1.26M$0—-$1.26M
Pfizer Inc.(PFE)196,1640-196,164$4.97M$0—-$4.97M
Schrödinger, Inc.(SDGR)14,1140-14,114$278.6K$0—-$278.6K
Springworks Therapeutics Inc54,2160-54,216$2.39M$0—-$2.39M
Summit Therapeutics Inc.(SMMT)132,0190-132,019$2.55M$0—-$2.55M
Taysha Gene Therapies, Inc.(TSHA)755,5990-755,599$1.05M$0—-$1.05M
Vaxcyte, Inc.(PCVX)11,2640-11,264$425.3K$0—-$425.3K
Verastem, Inc.(VSTM)336,3630-336,363$2.03M$0—-$2.03M
Page 1 of 1
SUPERSTRING CAPITAL MANAGEMENT LP — 13F Holdings — Q2 2025 | TickerTrail